A model for the number of cores per prostate biopsy based on patient age and prostate gland volume

被引:100
作者
Vashi, AR
Wojno, KJ
Gillespie, B
Oesterling, JE
机构
[1] Univ Michigan, Dept Pathol, Ann Arbor, MI 48019 USA
[2] Univ Michigan, Urol Sect, Ann Arbor, MI 48019 USA
关键词
prostate; cancer; diagnosis; biopsy;
D O I
10.1016/S0022-5347(01)63771-6
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: The systematic sextant biopsy is currently the gold standard for the tissue diagnosis of prostate cancer. However, it is unknown whether this 6 core approach provides optimal sampling of all prostate glands in men of all ages. The goal of the current study was to determine the appropriate number of cores per prostate biopsy based on patient age and prostate gland volume. Materials and Methods: Patient age and tumor volume doubling time were used to calculate life threatening, clinically significant tumor volumes at diagnosis for 5-year intervals of patient age. A mathematical model was created to determine the minimum number of cores necessary to identify these life threatening tumor volumes in prostate glands 10 to 80 cm.(3) without detecting clinically insignificant cancers. Results: Younger men and men with larger prostate glands require more than 6 cores to ensure the diagnosis of life threatening prostate cancer. These prostates are currently under sampled by sextant biopsy. In a select group of older men who require fewer than 6 cores sextant biopsy may over sample these prostates and lead to over treatment. Conclusions: The standard sextant biopsy provides optimal sampling of only a minority of prostate glands. An approach to prostate biopsy based on patient age and prostate gland volume maximizes the detection of clinically significant prostate cancer.
引用
收藏
页码:920 / 924
页数:5
相关论文
共 28 条
[1]   PATHOLOGICAL FEATURES OF HEREDITARY PROSTATE-CANCER [J].
BASTACKY, SI ;
WOJNO, KJ ;
WALSH, PC ;
CARMICHAEL, MJ ;
EPSTEIN, JI .
JOURNAL OF UROLOGY, 1995, 153 (03) :987-992
[2]  
Berges RR, 1995, CLIN CANCER RES, V1, P473
[3]   STAGING OF EARLY PROSTATE-CANCER - A PROPOSED TUMOR VOLUME-BASED PROGNOSTIC INDEX [J].
BOSTWICK, DG ;
GRAHAM, SD ;
NAPALKOV, P ;
ABRAHAMSSON, PA ;
DISANTAGNESE, PA ;
ALGABA, F ;
HOISAETER, PA ;
LEE, F ;
LITTRUP, P ;
MOSTOFI, FK ;
DENIS, L ;
SCHROEDER, F ;
MURPHY, GP .
UROLOGY, 1993, 41 (05) :403-411
[4]   SCREENING FOR PROSTATIC-CARCINOMA WITH PROSTATE SPECIFIC ANTIGEN [J].
BRAWER, MK ;
CHETNER, MP ;
BEATIE, J ;
BUCHNER, DM ;
VESSELLA, RL ;
LANGE, PH .
JOURNAL OF UROLOGY, 1992, 147 (03) :841-845
[5]   DETECTION OF ORGAN-CONFINED PROSTATE-CANCER IS INCREASED THROUGH PROSTATE-SPECIFIC ANTIGEN-BASED SCREENING [J].
CATALONA, WJ ;
SMITH, DS ;
RATLIFF, TL ;
BASLER, JW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (08) :948-954
[6]   COMPARISON OF DIGITAL RECTAL EXAMINATION AND SERUM PROSTATE-SPECIFIC ANTIGEN IN THE EARLY DETECTION OF PROSTATE-CANCER - RESULTS OF A MULTICENTER CLINICAL-TRIAL OF 6,630 MEN [J].
CATALONA, WJ ;
RICHIE, JP ;
AHMANN, FR ;
HUDSON, MA ;
SCARDINO, PT ;
FLANIGAN, RC ;
DEKERNION, JB ;
RATLIFF, TL ;
KAVOUSSI, LR ;
DALKIN, BL ;
WATERS, WB ;
MACFARLANE, MT ;
SOUTHWICK, PC .
JOURNAL OF UROLOGY, 1994, 151 (05) :1283-1290
[7]  
Chen Michael E., 1997, Journal of Urology, V157, P64
[8]  
CZAPO Z, 1988, J UROLOGY, V140, P1032
[9]   The definition and preoperative prediction of clinically insignificant prostate cancer [J].
Dugan, JA ;
Bostwick, DG ;
Myers, RP ;
Qian, JQ ;
Bergstralh, EJ ;
Oesterling, JE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (04) :288-294
[10]   PATHOLOGICAL AND CLINICAL FINDINGS TO PREDICT TUMOR EXTENT OF NONPALPABLE (STAGE-T1C) PROSTATE-CANCER [J].
EPSTEIN, JI ;
WALSH, PC ;
CARMICHAEL, M ;
BRENDLER, CB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (05) :368-374